Sector
MiscellaneousOpen
₹161.65Prev. Close
₹162Turnover(Lac.)
₹22.57Day's High
₹162.45Day's Low
₹161.6552 Week's High
₹052 Week's Low
₹0Book Value
₹344.66Face Value
₹10Mkt Cap (₹ Cr.)
574.07P/E
6.42EPS
25.25Divi. Yield
0No Record Found
Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 35.44 | 35.44 | 35.44 | 35.44 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,185.93 | 1,094.7 | 1,052.89 | 976.78 |
Net Worth | 1,221.37 | 1,130.14 | 1,088.33 | 1,012.22 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 |
---|---|---|---|---|
Revenue | 71.27 | 67.01 | 65.53 | 61.77 |
yoy growth (%) | 6.36 | 2.25 | 6.08 | 11.85 |
Raw materials | 0 | 0 | 0 | 0 |
As % of sales | 0 | 0 | 0 | 0 |
Employee costs | -0.08 | -0.07 | -0.08 | -0.15 |
Y/e 31 Mar( In .Cr) | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 |
---|---|---|---|---|
Profit before tax | 95.23 | 93.84 | 115.43 | 100.47 |
Depreciation | -2.38 | -2.22 | -2.38 | -3.29 |
Tax paid | -33.24 | -26.72 | -35.56 | -27.25 |
Working capital | 184.02 | 115.71 | 14.65 | -26.51 |
Other operating items |
Y/e 31 Mar | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 6.36 | 2.25 | 6.08 | 11.85 |
Op profit growth | -11.19 | -42.77 | 5.33 | 8.68 |
EBIT growth | 1.31 | -15.77 | 9.83 | 124.15 |
Net profit growth | -7.63 | -15.97 | 9.1 | 222.15 |
Particulars (Rupees in Crores.) | Dec-2002 | Dec-2001 |
---|---|---|
Gross Sales | 188 | 246.5 |
Excise Duty | 0 | 0 |
Net Sales | 188 | 246.5 |
Other Operating Income | 0 | 0 |
Other Income | 157.6 | 4 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
GMR Airports Ltd GMRAIRPORT | 77.36 | 0 | 81,684.24 | -49.43 | 0 | 270.92 | 45.21 |
OneSource Specialty Pharma Ltd ONESOURCE | 1,629.2 | 0 | 18,641.63 | -73.02 | 0 | 336.75 | 36.2 |
International Gemmological Institute (India) Ltd IGIL | 386.75 | 38.16 | 16,756.99 | 111.68 | 0.63 | 190.29 | 50.61 |
Embassy Developments Ltd EMBDL | 113.97 | 0 | 13,462.55 | -15.26 | 0 | 4.83 | 43.55 |
Rites Ltd RITES | 230.19 | 29.97 | 11,061.1 | 94.99 | 3.91 | 544.53 | 51.59 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director & CFO
Stephen D Souza
Chairman & Independent Directo
Akhtar Shamsi
Independent Director
Vijaya Nair
Company Sec. & Compli. Officer
Alwin Lopes
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Carol Info Services Ltd
Summary
Wockhardt was promoted by the Khorakiwala family in 1959 and was known as Worli Chemicals. In 1979, Wockhardt set up a new pharmaceutical plant at Aurangabad. A second company, Wockhardt Synchem, was floated to manufacture speciality bulk drugs, at Ankleshwar, Gujarat.With the demerger of its pharmaceutical division into a separate entity, the company has been renamed Wockhardt Life Science while the new company with the pharmaceutical division is now called Wockhardt. In 1989, it diversified into medical services by setting up a day-care facility, Wockhardt Medical and Research Centre at Calcutta. In 1990, Wockhardt set up an IV fluid manufacturing plant at Waluj with technical assistance from Pharmaplan, Germany. It also started a super-speciality hospital in Bangalore, specialising in cardiology, cardiac surgery and kidney transplants. In 1992, it commissioned its new bulk drugs plant and began work on its third bulk drug plant at Ankleshwar. It set up a subsidiary in Ireland, Wockhardt Europe, to promote exports. In 1994, Wockhardt floated a $ 75 mln GDR issue to raise the funds required for its expansion plans.It has enterered into a joint venture with Rhein Biotech, Germany, for research and development and manufacturing of biotechnology products. In 1995, Wockhardt received the national award for R&D efforts in the biotech industries by the Department of Science and Industrial Research. It has acquired Accumed Pharmaceuticals, US, with which it had a joint venture for
Read More
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.